Global Peptide Cancer Therapeutics Market (2021 to 2026) - Drug Dosage, Price & Clinical Trials Insight
Share this article Share this article ResearchAndMarkets.coms offering. This report provides insights into the potential application of peptide therapeutics and their mode of action in the management of different cancers. In addition to this, the report also provide data on the pricing, sales and dosage of the currently available peptide based therapeutics and the robust clinical pipeline which are expected to enter the market in next coming years. Moreover, the various key players which are in...
United States Plenaxis Abarelix Eligard Leuprolide Firmagon Degarelix Pegintron Peginterferon Suprefact Buserelin
Source: prnewswire.com